Northern Investors Company PLC

Northern Investors Company PLC was formed in 1984 to provide long-term investment finance for unquoted companies in the North of England. The company’s main objective is to achieve a substantial long-term increase in the value of its shareholders’ funds, by making equity investments in well-managed UK unquoted businesses with growth potential.

Northern Investors Company has been listed on the London Stock Exchange as an investment trust since 1990. Most of the shares are held by pension funds and other financial institutions and there are over 1,200 private investors.

The company’s share price carried daily in the Financial Times (under “Investment Companies - Conventional Trusts”), the Newcastle Journal and the Northern Echo. To obtain an updated share price please click here. Share price information is provided by the London Stock Exchange plc whose terms and conditions you will be required to accept in order to view the information.

The financial calendar for the year ending 31 March 2010 is as follows:

November 2009 Half-yearly report for six months to 30 September 2009 published

January 2010 Interim dividend paid

May 2010 Final dividend and results for year to 31 March 2010 announced; annual report and financial statements published

June 2010 Annual general meeting

July 2010 Final dividend paid

Northern Investors Company is a member of the Association of Investment Companies.

If you would like to receive a copy of the latest published annual report and accounts or half-yearly financial report, by post, please contact us. If you would like to download reports in PDF format, please click here.

Directors

Registrars:

Stockbrokers:

  • JPMorgan Cazenove Limited
  • Brewin Dolphin Limited

Auditors:

  • KPMG Audit Plc

Latest news

VCT for income: Northern 3 VCT 15 million share issue offer

Northern 3 VCT PLC has launched a public offer of 15 million new ordinary shares. For further information & the prospectus click here.

Abermed sold to
International SOS

NVM has sold its investment in Abermed, the UK occupational health and remote medical services company, to International SOS, the world's leading provider of integrated medical and security assistance, for an undisclosed consideration. For further information click here.

DxS sold to Qiagen –
record exit for NVM

NVM has sold DxS to Qiagen to create a global leader in personalised medicine for a value of $130 million ($95 million initial consideration plus earnouts of up to $35 million). For further information click here.